Biopol Chemicals Profile
Key Indicators
- Authorised Capital ₹ 12.50 Cr
as on 28-12-2024
- Paid Up Capital ₹ 7.91 Cr
as on 28-12-2024
- Company Age 1 Year 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 Cr
as on 28-12-2024
About Biopol Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.50 Cr and a paid-up capital of Rs 7.91 Cr.
The company currently has active open charges totaling ₹5.00 Cr.
The Key Managerial Personnel (KMP) at Biopol Chemicals Limited India are Komal Khesakani as COMPANY SECRETARY and Sandip Choudhury as Cfo. Preety Ghosh, Vedant Sarkar, Brahma Raval, and Two other members serve as directors at the Company.
- CIN/LLPIN
U20297GJ2023PLC140117
- Company No.
140117
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2023
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Biopol Chemicals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santanu Sarkar  | Managing Director | 12-Apr-2023 | Current |
| Komal Khesakani | Company Secretary | 18-May-2024 | Current |
| Sandip Choudhury | CFO | 15-Jul-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Preety Ghosh | Director | 01-Feb-2024 | Current |
| Vedant Sarkar | Whole-Time Director | 11-Aug-2023 | Current |
| Brahma Raval | Director | 06-Mar-2024 | Current |
| Sruti Chanda | Director | 01-May-2024 | Current |
Financial Performance of Biopol Chemicals.
Biopol Chemicals Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Biopol Chemicals?
Unlock access to Biopol Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 07 Mar 2024 | ₹5.00 Cr | Open |
How Many Employees Work at Biopol Chemicals?
Biopol Chemicals has a workforce of 0 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biopol Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biopol Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
